| Literature DB >> 30371579 |
Thibaut Cassou-Mounat, Laurence Champion1, Laurence Bozec2, Valerie Laurence3, Virginie Huchet, Marie Luporsi, Nina Jehanno.
Abstract
Breast angiosarcoma is a rare and aggressive tumor. The role of F-FDG PET/CT in breast angiosarcoma is poorly known. We report a series of 13 lesions in 11 patients with histologically proven primary or secondary breast angiosarcoma who underwent FDG PET/CT at the initial assessment in our institution. All breast lesions showed FDG avidity. Visually and statistically, we observed a significant difference of SUVmax uptake foci between primary and secondary breast angiosarcoma (Wilcoxon test P < 0.0046) and a significantly poorer prognosis for high SUVmax than those with low SUVmax (P = 0.049) regardless of primary or secondary origins.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30371579 DOI: 10.1097/RLU.0000000000002334
Source DB: PubMed Journal: Clin Nucl Med ISSN: 0363-9762 Impact factor: 7.794